ID

20524

Beskrivning

The Efficacy of CILostazol ON Ischemic Complications After DES Implantation; ODM derived from: https://clinicaltrials.gov/show/NCT00776828

Länk

https://clinicaltrials.gov/show/NCT00776828

Nyckelord

  1. 2017-03-01 2017-03-01 -
Uppladdad den

1 mars 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Coronary Artery Disease NCT00776828

Eligibility Coronary Artery Disease NCT00776828

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
subject must be at leat 18 years of age
Beskrivning

age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
Beskrivning

informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
subject must have significant coronary artery stenosis (>50% by visual estimate)
Beskrivning

Coronary Stenosis Percentage Visual estimation

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0242231
UMLS CUI [1,2]
C0439165
UMLS CUI [1,3]
C0444684
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
Beskrivning

Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0151744
UMLS CUI [1,2]
C0340288
UMLS CUI [1,3]
C0002965
UMLS CUI [1,4]
C1275835
UMLS CUI [1,5]
C0340291
UMLS CUI [1,6]
C1141959
UMLS CUI [1,7]
C0242231
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
Beskrivning

coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0242231
UMLS CUI [1,2]
C3526701
UMLS CUI [1,3]
C1262327
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
Beskrivning

Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1532297
UMLS CUI [1,2]
C1303258
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Beskrivning

hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1301624
UMLS CUI [1,3]
C2963157
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0004057
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C0070166
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C0055729
subject who has thrombocytopenia (<120,000/ul)
Beskrivning

platelet count measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0032181
subject who has liver cirrhosis (child class b or c)
Beskrivning

liver cirrhosis

Datatyp

boolean

Alias
UMLS CUI [1]
C0023890
subject who is on the anticoagulation therapy
Beskrivning

anticoagulation

Datatyp

boolean

Alias
UMLS CUI [1]
C0449867
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
Beskrivning

congestive heart failure, left ventricular ejection fraction

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0428772

Similar models

Eligibility Coronary Artery Disease NCT00776828

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
subject must be at leat 18 years of age
boolean
C0001779 (UMLS CUI [1])
informed consent
Item
subject is able to verbally confirm understandings of risks, benefits and treatment alternatives of cilostazol and he/she or his/her legally authorized representative provides written informed consent prior to any study related procedure.
boolean
C0021430 (UMLS CUI [1])
Coronary Stenosis Percentage Visual estimation
Item
subject must have significant coronary artery stenosis (>50% by visual estimate)
boolean
C0242231 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C0444684 (UMLS CUI [1,3])
Myocardial Ischemia; Stable angina; Angina, Unstable; History of myocardial infarction; Silent myocardial ischemia; ECG signs of myocardial ischaemia; Coronary Stenosis
Item
subject must have evidence of myocardial ischemia (e.g., stable, unstable angina, recent infarction, silent ischemia, positive functional study or reversible changes in the electrocardiogram (ecg) consistent with ischemia. in subjects with coronary artery stenosis>75%, evidence of myocardial ischemia does not have to be documented.
boolean
C0151744 (UMLS CUI [1,1])
C0340288 (UMLS CUI [1,2])
C0002965 (UMLS CUI [1,3])
C1275835 (UMLS CUI [1,4])
C0340291 (UMLS CUI [1,5])
C1141959 (UMLS CUI [1,6])
C0242231 (UMLS CUI [1,7])
coronary stenosis amenable for percutaneous coronary revascularization with drug eluting stents
Item
coronary lesions must be amenable for percutaneous coronary revascularization with drug eluting stents.
boolean
C0242231 (UMLS CUI [1,1])
C3526701 (UMLS CUI [1,2])
C1262327 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Emergency percutaneous coronary intervention; Acute ST segment elevation myocardial infarction
Item
subject who undergoes primary percutaneous coronary intervention due to acute st elevation myocardial infarction
boolean
C1532297 (UMLS CUI [1,1])
C1303258 (UMLS CUI [1,2])
hypersensitivity or contraindication to anti-platelet agents (aspirin, clopidogrel or cilostazol)
Item
subject who has contraindication or allergy to anti-platelet agents (aspirin, clopidogrel or cilostazol)
boolean
C0020517 (UMLS CUI [1,1])
C1301624 (UMLS CUI [1,2])
C2963157 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0070166 (UMLS CUI [3,2])
C0020517 (UMLS CUI [4,1])
C0055729 (UMLS CUI [4,2])
platelet count measurement
Item
subject who has thrombocytopenia (<120,000/ul)
boolean
C0032181 (UMLS CUI [1])
liver cirrhosis
Item
subject who has liver cirrhosis (child class b or c)
boolean
C0023890 (UMLS CUI [1])
anticoagulation
Item
subject who is on the anticoagulation therapy
boolean
C0449867 (UMLS CUI [1])
congestive heart failure, left ventricular ejection fraction
Item
subject who has severe congestive heart failure (left ventricular ejection fraction <30%)
boolean
C0018802 (UMLS CUI [1,1])
C0428772 (UMLS CUI [1,2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial